Mpm Asset Management LLC Q3 2022 vs. Q4 2022 13F Holdings Comparison

In the world of finance, tracking fund holdings changes is crucial. As an investor, it's vital to know which stocks are being bought and sold, and when. Mpm Asset Management LLC recently filed their Q3 2022 and Q4 2022 13F Holdings comparison. In this article, we will take a closer look at Mpm Asset Management LLC's latest holdings and any changes made as of Q4 2022.

One of the significant changes made by Mpm Asset Management LLC is that they have maintained their position in Entrada Therapeutics, Inc. with 4,425,784 shares. The Q3 2022 and Q4 2022 value of this holding is $69,750 and $59,836, respectively, a decrease of 14.2%.

Dyne Therapeutics, Inc. is another company in which Mpm Asset Management LLC has maintained its position, with 4,951,303 shares. However, the value of the shares has dropped from $62,882 in Q3 2022 to $57,385 in Q4 2022, a decrease of 8.7%.

On the other hand, Mpm Asset Management LLC has increased its position in iTeos Therapeutics, Inc. The fund now has 2,738,785 shares of the company, with a value of $53,488 in Q4 2022, up from $52,174 in Q3 2022, a change of 2.5%.

Repare Therapeutics, Inc. is another company in which Mpm Asset Management LLC has increased its position from Q3 2022 to Q4 2022. The fund now holds 2,242,636 shares, with a value of $32,989 in Q4 2022, up from $27,203 in Q3 2022, representing an increase in value of 21.3%.

Amryt Pharma plc is the next company that Mpm Asset Management LLC has maintained its position in, with 2,668,843 shares. The value of this holding has increased from $18,468 in Q3 2022 to $19,482 in Q4 2022, an increase of 5.5%.

Werewolf Therapeutics, Inc., however, saw a significant decrease in its value share for Mpm Asset Management LLC as they dropped from $19,322 in Q3 2022 to $8,782 in Q4 2022, a decrease of 54.5%. The number of shares in the company remained constant at 4,284,172.

Mpm Asset Management LLC has decreased its position in TCR2 Therapeutics, Inc. to 4,050,865 shares, with a value of $4046 in Q4 2022, down from $7292 in Q3 2022.

Harpoon Therapeutics, Inc. saw a decrease in both the number of shares held by Mpm Asset Management LLC and the value of these shares. The holdings dropped from 3,131,388 shares in Q3 2022 to 3,131,388 shares in Q4 2022, with a value of $2,273, a decrease of 25.1%.

Finally, Oncorus, Inc. saw a significant decrease in both the number of shares held and the share's value by Mpm Asset Management LLC. The number of shares dropped from 2,849,464 in Q3 2022 to 2,849,464 in Q4 2022, and the value of these shares decreased from $2,422 in Q3 2022 to $720 in Q4 2022, a decrease of 70.2%.

In conclusion, Mpm Asset Management LLC's latest 13F holdings comparison shows that they have maintained their position in some companies, increased their position in a few, and decreased their position in others. It is essential to keep track of these changes, as it can impact the stock's value and overall portfolio performance.